JP2020501516A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020501516A5 JP2020501516A5 JP2019522647A JP2019522647A JP2020501516A5 JP 2020501516 A5 JP2020501516 A5 JP 2020501516A5 JP 2019522647 A JP2019522647 A JP 2019522647A JP 2019522647 A JP2019522647 A JP 2019522647A JP 2020501516 A5 JP2020501516 A5 JP 2020501516A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- mouse
- gene segments
- light chain
- immunoglobulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000018358 Immunoglobulins Human genes 0.000 claims description 54
- 108060003951 Immunoglobulins Proteins 0.000 claims description 54
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims description 23
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims description 23
- 238000003780 insertion Methods 0.000 claims description 22
- 239000003623 enhancer Substances 0.000 claims description 19
- 230000002708 enhancing Effects 0.000 claims description 19
- 210000004602 germ cell Anatomy 0.000 claims description 14
- 229920002332 Noncoding DNA Polymers 0.000 claims description 10
- 108010002162 IGK Proteins 0.000 claims description 9
- 102100007034 Immunoglobulin kappa light chain Human genes 0.000 claims description 9
- 210000001671 Embryonic Stem Cells Anatomy 0.000 claims description 7
- 229920001850 Nucleic acid sequence Polymers 0.000 claims description 6
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 210000002308 embryonic cell Anatomy 0.000 claims 1
- 241000283984 Rodentia Species 0.000 description 81
- 210000004027 cells Anatomy 0.000 description 5
- 241000700159 Rattus Species 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000038129 antigens Human genes 0.000 description 3
- 108091007172 antigens Proteins 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 102000004965 antibodies Human genes 0.000 description 2
- 108090001123 antibodies Proteins 0.000 description 2
- 230000028993 immune response Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662417845P | 2016-11-04 | 2016-11-04 | |
| US62/417,845 | 2016-11-04 | ||
| US201762567932P | 2017-10-04 | 2017-10-04 | |
| US62/567,932 | 2017-10-04 | ||
| PCT/US2017/060006 WO2018128691A1 (en) | 2016-11-04 | 2017-11-03 | Non-human animals having an engineered immunoglobulin lambda light chain locus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021036180A Division JP2021090455A (ja) | 2016-11-04 | 2021-03-08 | 操作されたイムノグロブリンラムダ軽鎖座位を有する非ヒト動物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020501516A JP2020501516A (ja) | 2020-01-23 |
| JP2020501516A5 true JP2020501516A5 (es) | 2020-12-10 |
| JP6884860B2 JP6884860B2 (ja) | 2021-06-09 |
Family
ID=62025924
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019522647A Active JP6884860B2 (ja) | 2016-11-04 | 2017-11-03 | 操作されたイムノグロブリンラムダ軽鎖座位を有する非ヒト動物 |
| JP2021036180A Withdrawn JP2021090455A (ja) | 2016-11-04 | 2021-03-08 | 操作されたイムノグロブリンラムダ軽鎖座位を有する非ヒト動物 |
| JP2022109658A Active JP7386292B2 (ja) | 2016-11-04 | 2022-07-07 | 操作されたイムノグロブリンラムダ軽鎖座位を有する非ヒト動物 |
| JP2023023312A Pending JP2023053400A (ja) | 2016-11-04 | 2023-02-17 | 操作されたイムノグロブリンラムダ軽鎖座位を有する非ヒト動物 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021036180A Withdrawn JP2021090455A (ja) | 2016-11-04 | 2021-03-08 | 操作されたイムノグロブリンラムダ軽鎖座位を有する非ヒト動物 |
| JP2022109658A Active JP7386292B2 (ja) | 2016-11-04 | 2022-07-07 | 操作されたイムノグロブリンラムダ軽鎖座位を有する非ヒト動物 |
| JP2023023312A Pending JP2023053400A (ja) | 2016-11-04 | 2023-02-17 | 操作されたイムノグロブリンラムダ軽鎖座位を有する非ヒト動物 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US10820582B2 (es) |
| EP (3) | EP3407709B9 (es) |
| JP (4) | JP6884860B2 (es) |
| KR (4) | KR20240055863A (es) |
| CN (2) | CN109996441B (es) |
| AU (2) | AU2017391167B2 (es) |
| BR (1) | BR112019008675A2 (es) |
| CA (1) | CA3038720A1 (es) |
| CY (1) | CY1123491T1 (es) |
| DK (2) | DK3407709T3 (es) |
| ES (2) | ES2823305T3 (es) |
| HR (2) | HRP20220888T1 (es) |
| HU (2) | HUE052087T2 (es) |
| IL (2) | IL266282B2 (es) |
| LT (2) | LT3407709T (es) |
| MA (2) | MA53935A (es) |
| MX (2) | MX2019005256A (es) |
| PL (2) | PL3766343T3 (es) |
| PT (2) | PT3407709T (es) |
| RS (2) | RS60886B1 (es) |
| RU (2) | RU2757665C2 (es) |
| SG (2) | SG10201913483XA (es) |
| SI (2) | SI3766343T1 (es) |
| WO (1) | WO2018128691A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10662256B2 (en) | 2010-07-26 | 2020-05-26 | Trianni, Inc. | Transgenic mammals and methods of use thereof |
| RU2770016C2 (ru) * | 2012-02-01 | 2022-04-14 | Регенерон Фармасьютикалз, Инк. | Гуманизированные грызуны, которые экспрессируют тяжелые цепи, содержащие домены vl |
| EP3384030A4 (en) | 2015-12-03 | 2019-07-03 | Trianni, Inc. | IMPROVED IMMUNOGLULINIVITY |
| MA53935A (fr) | 2016-11-04 | 2021-12-22 | Regeneron Pharma | Animaux non humains ayant un locus à chaîne légère lambda d'immunoglobuline modifiée |
| SG11202008799PA (en) | 2018-03-24 | 2020-10-29 | Regeneron Pharma | Genetically modified non-human animals for generating therapeutic antibodies against peptide-mhc complexes, methods of making and uses thereof |
| TWI829679B (zh) | 2018-03-26 | 2024-01-21 | 美商再生元醫藥公司 | 用於測試治療藥劑之人類化囓齒動物 |
| IL305557A (en) | 2018-06-14 | 2023-10-01 | Regeneron Pharma | Non-human animals with transgenic DH–DH rearrangement capacity, and their uses |
| SG11202107589PA (en) | 2019-02-22 | 2021-08-30 | Regeneron Pharma | Rodents having genetically modified sodium channels and methods of use thereof |
| CN114554841B (zh) * | 2019-07-01 | 2024-06-11 | 特里安尼公司 | 转基因哺乳动物及其使用方法 |
| IL301137A (en) | 2020-09-11 | 2023-05-01 | Regeneron Pharma | Identification and production of antigen-specific antibodies |
| EP4262373A1 (en) | 2020-12-16 | 2023-10-25 | Regeneron Pharmaceuticals, Inc. | Mice expressing humanized fc alpha receptors |
| WO2022140494A1 (en) | 2020-12-23 | 2022-06-30 | Regeneron Pharmaceuticals, Inc. | Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same |
| AU2021410655A1 (en) | 2020-12-23 | 2023-06-29 | Regeneron Pharmaceuticals, Inc. | Nucleic acids encoding anchor modified antibodies and uses thereof |
| GB202217978D0 (en) * | 2022-11-30 | 2023-01-11 | Petmedix Ltd | Rodents expressing a common light chain |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0746609A4 (en) * | 1991-12-17 | 1997-12-17 | Genpharm Int | NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES |
| US5670356A (en) | 1994-12-12 | 1997-09-23 | Promega Corporation | Modified luciferase |
| US5874304A (en) | 1996-01-18 | 1999-02-23 | University Of Florida Research Foundation, Inc. | Humanized green fluorescent protein genes and methods |
| GB9823930D0 (en) | 1998-11-03 | 1998-12-30 | Babraham Inst | Murine expression of human ig\ locus |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US7105348B2 (en) | 2000-10-31 | 2006-09-12 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| CA2847885C (en) | 2001-11-30 | 2022-03-22 | Amgen Fremont Inc. | Transgenic animals bearing human ig.lambda. light chain genes |
| US7585668B2 (en) * | 2003-07-15 | 2009-09-08 | Therapeutic Human Polyclonals, Inc. | Humanized immunoglobulin loci |
| CN102585002A (zh) | 2006-06-02 | 2012-07-18 | 瑞泽恩制药公司 | 人il-6受体的高亲和力抗体 |
| LT2346994T (lt) | 2008-09-30 | 2022-03-10 | Ablexis, Llc | Knock-in pelė, skirta chimerinių antikūnų gamybai |
| WO2010070263A1 (en) * | 2008-12-18 | 2010-06-24 | Erasmus University Medical Center Rotterdam | Non-human transgenic animals expressing humanised antibodies and use therof |
| ES2537239T3 (es) * | 2009-07-08 | 2015-06-03 | Kymab Limited | Modelos de animales y moléculas terapéuticas |
| RU2425880C2 (ru) * | 2009-07-30 | 2011-08-10 | Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН | Способ получения трансгенных мышей |
| WO2011115476A1 (en) | 2010-03-17 | 2011-09-22 | N.V. Nutricia | Infant nutrition for improving fatty acid composition of brain membranes later in life |
| BR122020013427B1 (pt) | 2010-06-22 | 2021-08-03 | Regeneron Pharmaceuticals, Inc | Método para fazer um camundongo, uma célula ou tecido derivado de um camundongo e um hibridoma |
| CN103429746B (zh) | 2011-02-25 | 2016-05-11 | 瑞泽恩制药公司 | Adam6小鼠 |
| EP4074833A1 (en) | 2011-10-17 | 2022-10-19 | Regeneron Pharmaceuticals, Inc. | Restricted immunoglobulin heavy chain mice |
| US9253965B2 (en) * | 2012-03-28 | 2016-02-09 | Kymab Limited | Animal models and therapeutic molecules |
| RU2664181C2 (ru) * | 2011-12-20 | 2018-08-15 | Регенерон Фармасьютикалз, Инк. | Мыши с гуманизированной легкой цепью |
| KR20160025033A (ko) * | 2013-02-20 | 2016-03-07 | 리제너론 파마슈티칼스 인코포레이티드 | 변형된 면역글로불린 중쇄 서열을 갖는 비인간 동물 |
| SG11201505968WA (en) | 2013-02-20 | 2015-08-28 | Regeneron Pharma | Genetic modification of rats |
| US9788534B2 (en) * | 2013-03-18 | 2017-10-17 | Kymab Limited | Animal models and therapeutic molecules |
| DE112014004537T5 (de) * | 2013-10-01 | 2016-07-21 | Kymab Limited | Tiermodelle und therapeutische Moleküle |
| CA2933433C (en) | 2013-12-11 | 2020-11-17 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for the targeted modification of a genome |
| HUE049776T2 (hu) | 2014-06-06 | 2020-10-28 | Regeneron Pharma | Módszerek és készítmények egy célzott lókusz módosítására |
| EP3155099B1 (en) | 2014-06-23 | 2018-03-21 | Regeneron Pharmaceuticals, Inc. | Nuclease-mediated dna assembly |
| SI3221457T1 (sl) | 2014-11-21 | 2019-08-30 | Regeneron Pharmaceuticals, Inc. | Postopki in sestavki za ciljno genetsko modifikacijo z uporabo vodilnih RNK v parih |
| KR102530821B1 (ko) | 2014-12-19 | 2023-05-10 | 리제너론 파마슈티칼스 인코포레이티드 | 단일 단계 다중 표적화를 통한 표적화된 유전자 변형을 위한 방법 및 조성물 |
| MA53935A (fr) | 2016-11-04 | 2021-12-22 | Regeneron Pharma | Animaux non humains ayant un locus à chaîne légère lambda d'immunoglobuline modifiée |
-
2017
- 2017-11-03 MA MA053935A patent/MA53935A/fr unknown
- 2017-11-03 ES ES17863293T patent/ES2823305T3/es active Active
- 2017-11-03 BR BR112019008675A patent/BR112019008675A2/pt unknown
- 2017-11-03 ES ES20180508T patent/ES2915609T3/es active Active
- 2017-11-03 PL PL20180508.2T patent/PL3766343T3/pl unknown
- 2017-11-03 HR HRP20220888TT patent/HRP20220888T1/hr unknown
- 2017-11-03 CN CN201780067880.6A patent/CN109996441B/zh active Active
- 2017-11-03 RU RU2019112589A patent/RU2757665C2/ru active
- 2017-11-03 KR KR1020247012338A patent/KR20240055863A/ko active Search and Examination
- 2017-11-03 KR KR1020237002504A patent/KR102658529B1/ko active IP Right Grant
- 2017-11-03 CA CA3038720A patent/CA3038720A1/en active Pending
- 2017-11-03 DK DK17863293.1T patent/DK3407709T3/da active
- 2017-11-03 LT LTEP17863293.1T patent/LT3407709T/lt unknown
- 2017-11-03 MX MX2019005256A patent/MX2019005256A/es unknown
- 2017-11-03 KR KR1020217034468A patent/KR102492433B1/ko active IP Right Grant
- 2017-11-03 RU RU2021129958A patent/RU2021129958A/ru unknown
- 2017-11-03 HU HUE17863293A patent/HUE052087T2/hu unknown
- 2017-11-03 DK DK20180508.2T patent/DK3766343T3/da active
- 2017-11-03 LT LTEP20180508.2T patent/LT3766343T/lt unknown
- 2017-11-03 IL IL266282A patent/IL266282B2/en unknown
- 2017-11-03 US US15/803,513 patent/US10820582B2/en active Active
- 2017-11-03 RS RS20201205A patent/RS60886B1/sr unknown
- 2017-11-03 KR KR1020197015717A patent/KR102319069B1/ko active IP Right Grant
- 2017-11-03 EP EP17863293.1A patent/EP3407709B9/en active Active
- 2017-11-03 WO PCT/US2017/060006 patent/WO2018128691A1/en active Application Filing
- 2017-11-03 EP EP20180508.2A patent/EP3766343B1/en active Active
- 2017-11-03 MA MA044091A patent/MA44091A/fr unknown
- 2017-11-03 AU AU2017391167A patent/AU2017391167B2/en active Active
- 2017-11-03 SG SG10201913483XA patent/SG10201913483XA/en unknown
- 2017-11-03 PT PT178632931T patent/PT3407709T/pt unknown
- 2017-11-03 HU HUE20180508A patent/HUE061980T2/hu unknown
- 2017-11-03 SG SG11201903344XA patent/SG11201903344XA/en unknown
- 2017-11-03 SI SI201731147T patent/SI3766343T1/sl unknown
- 2017-11-03 IL IL308197A patent/IL308197A/en unknown
- 2017-11-03 RS RS20220669A patent/RS63390B1/sr unknown
- 2017-11-03 SI SI201730381T patent/SI3407709T1/sl unknown
- 2017-11-03 JP JP2019522647A patent/JP6884860B2/ja active Active
- 2017-11-03 PL PL17863293T patent/PL3407709T3/pl unknown
- 2017-11-03 CN CN202210050898.8A patent/CN114369157A/zh active Pending
- 2017-11-03 PT PT201805082T patent/PT3766343T/pt unknown
- 2017-11-03 EP EP22164751.4A patent/EP4082334A1/en active Pending
-
2019
- 2019-05-03 MX MX2021010556A patent/MX2021010556A/es unknown
-
2020
- 2020-09-03 HR HRP20201403TT patent/HRP20201403T1/hr unknown
- 2020-09-24 US US17/031,367 patent/US20210029978A1/en active Pending
- 2020-10-29 CY CY20201101022T patent/CY1123491T1/el unknown
-
2021
- 2021-03-08 JP JP2021036180A patent/JP2021090455A/ja not_active Withdrawn
-
2022
- 2022-07-07 JP JP2022109658A patent/JP7386292B2/ja active Active
-
2023
- 2023-02-17 JP JP2023023312A patent/JP2023053400A/ja active Pending
-
2024
- 2024-01-31 AU AU2024200582A patent/AU2024200582A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020501516A5 (es) | ||
| JP2015505477A5 (es) | ||
| JP2018138047A5 (es) | ||
| US20200190218A1 (en) | Enhanced production of immunoglobulins | |
| JP2021137030A5 (es) | ||
| RU2014133653A (ru) | Гуманизированные грызуны, которые экспрессируют тяжелые цепи, содержащие домены vl | |
| JP2015519076A5 (es) | ||
| RU2021129958A (ru) | Отличные от человека животные со сконструированным локусом легкой лямбда-цепи иммуноглобулина | |
| DK2825036T3 (en) | Histidine engineered light chain antibodies and genetically modified rodents to generate them | |
| JP2017509355A5 (es) | ||
| JP2015502177A5 (es) | ||
| CN109072191A (zh) | 用于蛋白生产和文库产生的哺乳动物细胞系 | |
| CN102558355B (zh) | 基于电荷网络的异二聚体fc改造方法及异二聚体蛋白的制备方法 | |
| RU2014127339A (ru) | Мыши с гуманизированной легкой цепью | |
| JP2013535213A5 (es) | ||
| JP2015510767A5 (es) | ||
| JP2014524243A5 (es) | ||
| HRP20171357T1 (hr) | Ograničeni teški lanac imunoglobulina u miševa | |
| RU2016141307A (ru) | Отличные от человека животные, которые вырабатывают однодоменные связывающие белки | |
| JP2016512034A5 (es) | ||
| JP6391574B2 (ja) | 種間標的内交差反応性を有する抗体分子を産生する方法 | |
| RU2014153673A (ru) | Гуманизированные не относящиеся к человеку животные с ограниченными локусами тяжелой цепи иммуноглобулина | |
| JP2014110814A5 (es) | ||
| JP2013532974A5 (es) | ||
| RU2019121863A (ru) | Антитела со встроенным в легкие цепи гистидином и генетически модифицированные отличные от человека животные для их получения |